CD28 and immunoglobulin G4-related sclerosing disease: In addition, the current study did not address the clinical value of circulating CD28- CTL levels in the diagnosis of IgG4-RD patients, because it is difficult to collect a sufficient number of primary patients to elucidate its clinical value, which will be investigated in systematic research in the future.